SOD1 inhibition enhances sorafenib efficacy in HBV-related hepatocellular carcinoma by modulating PI3K/Akt/mTOR pathway and ROS-mediated cell death.
Lee J, Kim J, Lee R, Lee E, An HI, Kwon YJ, Jin H, Pack CG, Kim I, Yoon YI, Park GC, Jwa EK, Kwon JH, Namgoong JM, Song GW, Hwang S, Tak E, Lee SG.
Lee J, et al. Among authors: park gc.
J Cell Mol Med. 2024 Jul;28(14):e18533. doi: 10.1111/jcmm.18533.
J Cell Mol Med. 2024.
PMID: 39034442
Free PMC article.